Partners in TBVAC2020 are:

Australia
•      University of Sydney

Belgium
•      Ghent University
•      GSK Biologicals
•      Scientific Institute of Public Health (WIV-ISP)
•      Université Libre de Bruxelles

Denmark
•      Statens Serum Institut (SSI)

France
•      Centre National de la Recherche Scientifique (CNRS)
•      Institut Pasteur de Lille
•      Institut Pasteur (Paris)
•      Transgene

Germany
•      Max-Planck-Institute for Infection Biology
•      Friedrich-Loeffler-Institut
•      University of  Ulm

Ireland
•      University College Dublin

Italy
•      Azienda Ospedaliera Universitaria Policlinico “Paolo Giaccone” di Palermo
•      IRCCS Lazzaro Spallanzani
•      Istituto Superiore Di Sanità (ISS)

Republic of Korea
•      Yonsei University College of Medicine
•      International Tuberculosis Research Center

South Africa
•      K-Rith Kwazulu-Natal Research Institute for Tuberculosis
•      SATVI
•      Stellenbosch University
•      University of Cape Town

Spain
•      Fundació Institut d’ Investigació en Ciències de la Salut Germans Trias i Pujol
•      University of Zaragoza 

Switzerland
•      Centre Hospital Universitaire Vaudois
•      ETH Zürich – Institute of Molecular Systems Biology
•      University of Basel
•      University of Geneva
•      University of Lausanne
•      University of Zürich

The Gambia
•      Medical Research Council

The Netherlands
•      Biomedical Primate Research Centre (BPRC)
•      Leiden University Medical Center (LUMC)
•      Tuberculosis Vaccine Initiative (TBVI)

United Kingdom
•      Aston University
•      Bangor University
•      Imperial College, Faculty of Medicine, Department of Medicine & School of Public Health
•      London School of Hygiene and Tropical Medicine (LSHTM)
•      The secretary of state for health (DH) acting through PHE and MHRA
•      University of Oxford
•      Animal and Plant Health Agency (APHA)

United States of America
•      Aeras